Fig. 7
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Principal component analysis plots. (A) 2D projection of USP21, USP21-Ranmogenin (A), USP21-Tokorogenin, and USP21-BAY-805. (B) Time-evolution projection of USP21, USP21-Ranmogenin A, USP21-Tokorogenin, and USP21-BAY-805. Black, orange, aqua and purple represent values for USP21, USP21-Ranmogenin A, USP21-Tokorogenin, and USP21-BAY-805, respectively.
